ERS 2019: Omalizumab Linked to Comparable Responses in Patients With Allergic and Nonallergic Asthma
The therapy also reduced FceI expression on dendritic cells and improved antiviral responses.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.